MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities -
short term
$200,450K
Cash and cash
equivalents
$84,220K
Prepaid expenses
$8,736K
Accounts receivable
$5,936K
Other current assets
$3,895K
Interest receivable
$1,969K
Restricted cash - short term
$494K
Property, and equipment,
gross
$13,292K
Total current assets
$305,700K
Marketable securities -
long term
$106,260K
Property and equipment,
net
$3,146K
Operating lease
right-of-use assets
$3,101K
Restricted cash - long term
$227K
Less accumulated
depreciation
$10,146K
Total assets
$418,434K
Total liabilities and
stockholders equity
$418,434K
Total stockholders
equity
$352,457K
Total liabilities
$65,977K
Accumulated deficit
-$497,715K
Additional paid-in capital
$849,624K
Total current
liabilities
$57,875K
Total long term
liabilities
$8,102K
Accumulated other
comprehensive income (loss)
$543K
Common stock, par value
of 0.0001 per share...
$5K
Accrued and other
current liabilities
$41,035K
Deferred revenue -
current portion
$11,901K
Accounts payable
$4,939K
Deferred revenue - net of
current portion
$6,961K
Other long term
liabilities
$1,141K
Back
Back
Balance Sheet
source: myfinsight.com
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)